# Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection

> **NCT04674774** · NA · UNKNOWN · sponsor: **Incheon St.Mary's Hospital** · enrollment: 217 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT04674774
- **Lead sponsor:** Incheon St.Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-04
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-03-31
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2022-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674774, "Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04674774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*